Incannex Healthcare Ltd Stock Analysis

Incannex Stock Analysis Notes

About 12.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.21. Some equities with similar Price to Book (P/B) outperform the market in the long run. Incannex Healthcare recorded a loss per share of 0.8. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 30th of November 2023. Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies in Australia. Incannex Healthcare Limited was incorporated in 2001 and is based in Melbourne, Australia. Incannex Healthcare is traded on NASDAQ Exchange in the United States. To learn more about Incannex Healthcare Ltd call Joel Latham at 61 4 0984 0786 or check out https://www.incannex.com.

Incannex Healthcare Investment Alerts

Incannex Largest EPS Surprises

View All Earnings Estimates

Incannex Stock Institutional Investors

Note, although Incannex Healthcare's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Incannex Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 100.87 M.

Incannex Profitablity

Management Efficiency

Incannex Healthcare has return on total asset (ROA) of (0.3696) % which means that it has lost $0.3696 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3043) %, meaning that it created substantial loss on money invested by shareholders. Incannex Healthcare's management efficiency ratios could be used to measure how well Incannex Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -2.77. The value of Return On Capital Employed is expected to slide to -2.13. At this time, Incannex Healthcare's Other Current Assets are quite stable compared to the past year. Total Current Assets is expected to rise to about 24.1 M this year, although the value of Non Current Assets Total will most likely fall to about 414.7 K.

Technical Drivers

As of the 20th of February, Incannex Healthcare retains the Standard Deviation of 5.3, risk adjusted performance of (0.03), and Market Risk Adjusted Performance of (0.08). Incannex Healthcare technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Incannex Healthcare market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Incannex Healthcare is priced fairly, providing market reflects its last-minute price of 0.28 per share. As Incannex Healthcare appears to be a penny stock we also urge to confirm its jensen alpha numbers.

Incannex Healthcare Price Movement Analysis

Incannex Healthcare Insider Trading Activities

Incannex Healthcare Outstanding Bonds

Incannex Healthcare Predictive Daily Indicators

Incannex Healthcare Forecast Models

Incannex Healthcare's time-series forecasting models are one of many Incannex Healthcare's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Incannex Healthcare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Incannex Healthcare Bond Ratings

Incannex Healthcare Ltd financial ratings play a critical role in determining how much Incannex Healthcare have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Incannex Healthcare's borrowing costs.

Incannex Healthcare Debt to Cash Allocation

Incannex Healthcare Ltd currently holds 258 K in liabilities. Incannex Healthcare has a current ratio of 18.46, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Incannex Healthcare's use of debt, we should always consider it together with its cash and equity.

Incannex Healthcare Total Assets Over Time

Incannex Healthcare Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Incannex Healthcare uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Incannex Healthcare Debt Ratio

1.08

It seems most of the Incannex Healthcare's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Incannex Healthcare's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Incannex Healthcare, which in turn will lower the firm's financial flexibility.

Incannex Healthcare Corporate Bonds Issued

Incannex Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Incannex Healthcare prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Incannex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Incannex Healthcare. By using and applying Incannex Stock analysis, traders can create a robust methodology for identifying Incannex entry and exit points for their positions.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incannex Healthcare Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Incannex Healthcare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.